3.4.2 Allergen immunotherapy
Benralizumab
Fasenra 30mg/1ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Respiratory system | Asthma |
Dupilumab
Dupixent 200mg/1.14ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Respiratory system | Asthma |
Dupixent 200mg/1.14ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Respiratory system | Asthma |
Dupixent 300mg/2ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Respiratory system | Asthma |
Dupixent 300mg/2ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Respiratory system | Asthma |
Mepolizumab
Omalizumab
Xolair 150mg/1ml solution for injection pre-filled syringes
Xolair 75mg/0.5ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Respiratory system | Asthma |
Tezepelumab
Tezspire 210mg/1.91ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Respiratory system | Asthma |
Tezspire 210mg/1.91ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Respiratory system | Asthma |